Drug vignettes: Azithromycin
Description of the drug, including regulatory status: Azithromycin is a macrolide antibacterial drug, derived from erythromycin, licensed in the USA and in the UK, and used to treat bacterial infections. It has been used in combination with hydroxychloroquine in the treatment of COVID-19. However, t...
| Autores principales: | , |
|---|---|
| Formato: | Published Article |
| Publicado: |
2020-05-13
|
| Materias: | |
| Acceso en línea: | https://www.cebm.net/covid-19/drug-vignettes-azithromycin/ https://hdl.handle.net/20.500.12663/1576 |
| id |
PAO-20.500.12663-1576 |
|---|---|
| record_format |
dspace |
| spelling |
Ferner, Robin E. Aronson, Jeffrey K. 2020-05-21T16:57:59Z 2020-05-21T16:57:59Z 2020-05-13 https://www.cebm.net/covid-19/drug-vignettes-azithromycin/ https://hdl.handle.net/20.500.12663/1576 Description of the drug, including regulatory status: Azithromycin is a macrolide antibacterial drug, derived from erythromycin, licensed in the USA and in the UK, and used to treat bacterial infections. It has been used in combination with hydroxychloroquine in the treatment of COVID-19. However, there is an adverse drug–drug interaction between the two, which contraindicates their combined use. English COVID-19 Coronavirus Infectious Diseases Azithromycin Drug vignettes: Azithromycin Centre for Evidence-Based Medicine Others Candidate therapeutics RD Published Article Save Lives / Salvar Vidas |
| elec_str_mv |
Organización Panamericana de la Salud |
| collection |
Organización Panamericana de la Salud |
| title |
Drug vignettes: Azithromycin |
| spellingShingle |
Drug vignettes: Azithromycin Ferner, Robin E. Aronson, Jeffrey K. COVID-19 Coronavirus Infectious Diseases Azithromycin |
| title_short |
Drug vignettes: Azithromycin |
| title_full |
Drug vignettes: Azithromycin |
| title_fullStr |
Drug vignettes: Azithromycin |
| title_full_unstemmed |
Drug vignettes: Azithromycin |
| title_sort |
drug vignettes: azithromycin |
| author |
Ferner, Robin E. Aronson, Jeffrey K. |
| author_facet |
Ferner, Robin E. Aronson, Jeffrey K. |
| topic |
COVID-19 Coronavirus Infectious Diseases Azithromycin |
| topic_facet |
COVID-19 Coronavirus Infectious Diseases Azithromycin |
| publishDate |
2020-05-13 |
| format |
Published Article |
| description |
Description of the drug, including regulatory status: Azithromycin is a macrolide antibacterial drug, derived from erythromycin, licensed in the USA and in the UK, and used to treat bacterial infections. It has been used in combination with hydroxychloroquine in the treatment of COVID-19. However, there is an adverse drug–drug interaction between the two, which contraindicates their combined use.
|
| url |
https://www.cebm.net/covid-19/drug-vignettes-azithromycin/ https://hdl.handle.net/20.500.12663/1576 |
| work_keys_str_mv |
AT fernerrobine drugvignettesazithromycin AT aronsonjeffreyk drugvignettesazithromycin |
| _version_ |
1737882621952655360 |